Advertisement

Reactions Weekly

, Volume 1696, Issue 1, pp 172–172 | Cite as

Gefitinib

Development of gefitinib resistance in stage IV squamous cell lung cancer: case report
Case report

Reference

  1. Shen X, et al. Detection and monitoring of driver mutations by next-generation sequencing in squamous cell lung cancer patient and possible predictive biomarker of third generation EGFR-tyrosine kinase inhibitors. Thoracic Cancer 9: 181-184, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1111/1759-7714.12551 - ChinaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations